Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Large Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 756 shares, a drop of 66.6% from the June 30th total of 2,265 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 11,543 shares, the days-to-cover ratio is presently 0.1 days.

Fidelity Disruptive Medicine ETF Trading Up 0.8%

NASDAQ:FMED traded up $0.23 during mid-day trading on Tuesday, hitting $28.60. The company’s stock had a trading volume of 2,503 shares, compared to its average volume of 11,874. The stock has a fifty day moving average of $26.92 and a 200-day moving average of $26.09. The company has a market capitalization of $45.76 million, a price-to-earnings ratio of 41.33 and a beta of 0.74. Fidelity Disruptive Medicine ETF has a fifty-two week low of $22.80 and a fifty-two week high of $30.33.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A number of hedge funds have recently made changes to their positions in FMED. Glass Jacobson Investment Advisors llc boosted its position in Fidelity Disruptive Medicine ETF by 44.0% in the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after buying an additional 385 shares in the last quarter. Virtu Financial LLC bought a new stake in Fidelity Disruptive Medicine ETF during the 4th quarter worth approximately $228,000. Vise Technologies Inc. acquired a new stake in Fidelity Disruptive Medicine ETF during the 4th quarter valued at $234,000. BXM Wealth LLC bought a new position in Fidelity Disruptive Medicine ETF in the 4th quarter valued at $243,000. Finally, Jane Street Group LLC raised its position in Fidelity Disruptive Medicine ETF by 0.8% in the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after purchasing an additional 499 shares during the last quarter.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.